Announce Date | 05/01/2025 |
EPS Normalized Actual | $2.09 (Beat by $0.15) |
EPS GAAP Actual | $2.09 (Beat by $0.15) |
Revenue Actual | $2.80542B |
Revenue Surprise | Beat by $2805.42M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 8.42697 | 20.94 | 8.26474 | 8.59811 | 3 |
Dec 2028 | 11.52944 | 15.31 | 11.4154 | 11.79025 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.10602 | 1.10602 | 2.80542B | -15.95% | 2805.42M |
FQ4 2024 (Dec 2024) | 3.93 | 3.93 | 2.88754B | -4.93% | 2887.54M |
FQ3 2024 (Sep 2024) | 0 | 0 | 2.98749B | 99.92% | 2987.49M |
FQ2 2024 (Jun 2024) | 0.886 | 0.886 | 2.07448B | -44.02% | 2074.48M |
FQ1 2024 (Mar 2024) | 3.9 | 3.9 | 3.25275B | 100% | 3252.75M |
FQ4 2023 (Oct 2023) | 2.6 | 2.6 | 3.02999B | 9.96% | 3029.99M |
FQ3 2023 (Jul 2023) | 1.98 | 1.98 | 0.0024903B | -95172.86% | 2.49M |
FQ2 2023 (Apr 2023) | 0 | 0 | 2.98761B | 100% | 2987.61M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.7508 | -- | 1.70536 | 1.81598 | 5 |
FQ3 2027 (Sep 2027) | 1.7174 | -- | 1.67283 | 1.78134 | 3 |
FQ2 2027 (Jun 2027) | 1.1038 | -- | 1.07516 | 1.14489 | 3 |
FQ1 2027 (Mar 2027) | 2.0227 | -- | 1.97021 | 2.098 | 5 |
FQ4 2026 (Oct 2026) | 2.95518 | -- | 2.87517 | 3.05039 | 3 |
FQ3 2026 (Jul 2026) | 1.7902 | -- | 1.74173 | 1.84787 | 4 |
FQ2 2026 (Jun 2026) | 1.46427 | -- | 1.41933 | 1.51506 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.11B | -- | 3.05B | 3.2B | 4 |
FQ3 2027 (Sep 2027) | 3.23B | -- | 3.17B | 3.33B | 4 |
FQ2 2027 (Jun 2027) | 2.25B | -- | 2.2B | 2.31B | 4 |
FQ1 2027 (Mar 2027) | 3.51B | -- | 3.44B | 3.61B | 4 |
FQ4 2026 (Oct 2026) | 3.28B | -- | 3.21B | 3.36B | 4 |
FQ3 2026 (Jul 2026) | 2.6B | -- | 2.54B | 2.66B | 5 |
FQ2 2026 (Jun 2026) | 2.34B | -- | 2.28B | 2.4B | 8 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
0
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.10602 | 1.10602 | 100% | |
FQ4 2024 (Dec 2024) | 3.93 | 3.93 | 100% | |
FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
FQ2 2024 (Jun 2024) | 0.886 | 0.886 | 100% | |
FQ1 2024 (Mar 2024) | 3.9 | 3.9 | 100% | |
FQ4 2023 (Oct 2023) | 2.6 | 2.6 | 100% | |
FQ3 2023 (Jul 2023) | 1.98 | 1.98 | 100% | |
FQ2 2023 (Apr 2023) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $2.81B | $2805.42M | 100% |
FQ4 2024 (Dec 2024) | $0B | $2.89B | $2887.54M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.99B | $2987.49M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.07B | $2074.48M | 100% |
FQ1 2024 (Mar 2024) | $0B | $3.25B | $3252.75M | 100% |
FQ4 2023 (Oct 2023) | $0B | $3.03B | $3029.99M | 100% |
FQ3 2023 (Jul 2023) | $0B | $0B | $2.49M | 100% |
FQ2 2023 (Apr 2023) | $0B | $2.99B | $2987.61M | 100% |